[ Arzeda raises $12M in Series A ]

Arzeda has raised $12 million in Series A funding.

Founded in 2008, Arzeda develops enzyme design technology to create entirely novel designer cell factories capable of industry-scale chemical production.

The new investment will accelerate scale-up of Arzeda’s advanced protein design technology that can deliver revolutionary new production pathways for a wide range of valuable chemicals and materials, and serve more partners at greater scale.

Funding  Series A
Founded  2008
Country  USA
City  Seattle, WA
Founder / CEO  Alexandre Zanghellini
Deal Size  $12M
Investors  Bioeconomy Capital
 WRF Capital
 OS Fund
 Conversion Ventures LLC
Previous Investors  WRF Capital